Prevention and treatment of diabetic nephropathy
Data up to Jan 2025
Total Citations Per Year
Abstract
References (23)
The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus
1993 • 23,535 citations
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
1998 • 19,638 citations
Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and Hospitalization
2004 • 10,671 citations
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.
1998 • 8,603 citations
MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial
2003 • 2,931 citations
Relation between Renal Dysfunction and Cardiovascular Outcomes after Myocardial Infarction
2004 • 1,882 citations
Positionally Cloned Gene for a Novel Glomerular Protein—Nephrin—Is Mutated in Congenital Nephrotic Syndrome
1998 • 1,822 citations
Nephropathy in Diabetes
2004 • 1,040 citations
Preventing Microalbuminuria in Type 2 Diabetes
2004 • 1,000 citations
National Kidney Foundation K/DOQI Clinical Practice Guidelines for Nutrition in Chronic Renal Failure
2001 • 999 citations
Albuminuria, a Therapeutic Target for Cardiovascular Protection in Type 2 Diabetic Patients With Nephropathy
2004 • 729 citations
Nephrin Expression Is Reduced in Human Diabetic Nephropathy
2003 • 338 citations
Irbesartan normalises the deficiency in glomerular nephrin expression in a model of diabetes and hypertension
2001 • 242 citations
Proteinuria and the expression of the podocyte slit diaphragm protein, nephrin, in diabetic nephropathy: effects of angiotensin converting enzyme inhibition
2002 • 224 citations
Why is proteinuria an ominous biomarker of progressive kidney disease?
2004 • 166 citations
Clinical Pharmacokinetics and Pharmacodynamics of Repaglinide
2002 • 143 citations
The pharmacokinetics of pioglitazone in patients with impaired renal function
2003 • 141 citations
Management of drugs affecting blood glucose in diabetic patients with renal failure.
2000 • 132 citations
Pharmacokinetics of Rosiglitazone in Patients with Varying Degrees of Renal Insufficiency
2003 • 77 citations
Receptors for proteins modified by advanced glycation endproducts (AGE)—their functional role in atherosclerosis
1999 • 62 citations
Pharmacokinetics of Nateglinide in Renally Impaired Diabetic Patients
2003 • 34 citations
Suicide of the nephron
2001 • 26 citations
Oral hypoglycaemics. When not to use what.
2002 • 4 citations